Yes! This deal with the Canary acquisition and Cornell connection will be huge if it all goes through with the $50 million in funding for it. This will be a major milestone for Regen BioPharma. It would be the biggest deal yet and would have a major impact on the stock. Perhaps more so than the licensing deals with Oncology Pharma, and look what those did for the stock! Happy New Year 2022! :-)
News 
Market Data 
Discover 
